Ligand validation:3N5S

XFK: 6-(2-{5-[2-(2-amino-6-methylpyridin-4-yl)ethyl]pyridin-3-yl}ethyl)-4-methylpyridin-2-amine

XFK is a Ligand Of Interest in 3N5S designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3N5S_XFK_B_800	37%	32%	0.191	0.887	0.55	2.11	-	11	2	0	100%	1
3N5S_XFK_A_800	36%	32%	0.206	0.899	0.69	1.96	-	13	2	0	100%	1
3N6G_XFK_A_800	37%	30%	0.191	0.89	0.79	1.95	1	12	5	0	100%	1
3N6A_XFK_B_800	18%	41%	0.298	0.887	0.38	1.89	-	11	1	0	100%	1
3N5X_XFK_B_805	59%	42%	0.143	0.926	0.6	1.64	-	9	1	0	100%	1
4UG5_XFK_A_904	33%	46%	0.2	0.879	0.24	1.8	-	13	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.